059 - The five oncology drugs every pharmacist should know about
In this episode, we discuss with Dr. Megan Hartranft the five oncology drugs that every pharmacist should know about, which is a great review for P4 students who are currently preparing for the NAPLEX. We cover cyclophosphamide, cisplatin, methotrexate, doxorubicin, and vincristine.
11 Apr 2017
071 - Holy Hypertension Guidelines - Holiday Edition!
In this episode, we review the important changes in 2017 ACC/AHA guidelines for hypertension management in adults.
19 Dec 2017
043 - Review of Diabetic Ketoacidosis (DKA)
In this episode, we review the clinical presentation and treatment of diabetic ketoacidosis (DKA).
10 May 2016
106 - It’s Finally Here! The 2019 IDSA CAP Guidelines
In this episode, we discuss the important updates in the 2019 IDSA Community Acquired Pneumonia (CAP) guidelines with Dr. Christie Bertram, PharmD, an Infectious Diseases Clinical Pharmacist and Assistant Professor at Rosalind Franklin University’s College of Pharmacy.
24 Dec 2019
Most Popular Podcasts
076 - The New Move: Treating Tardive Dyskinesia
In this episode, we discuss two new agents (valbenazine and deutetrabenazine) -- the first of their kind to receive FDA approval to manage tardive dyskinesia most commonly associated with antipsychotic use.
3 Apr 2018
018 - HIV
In this episode, we review HIV therapy with Dr. Cottreau with a particular focus on Truvada, Atripla, Complera, Stribild, and Triumeq.
2 Dec 2014
052 - Drug Mixology and Dangerous Consequences, Part I
In this episode, we discuss some of the most important drug interactions, including serotonin syndrome, St. John's wort, statins and CYP inhibitors, and antihypertensive medications with NSAIDs.
15 Nov 2016
072 - Drop It Like It’s Hot: Prazosin and the 2017 VA/DoD PTSD Guidelines
In this episode, we will review the surprising results of the VA/DoD's 2017 Clinical Practice Guidelines on Management of PTSD, particularly as it relates to the use of one particular agent, prazosin.
9 Jan 2018
057 - Kicking acid, taking names ... the story of PPI use and abuse
In this episode, we discuss the overuse of proton pump inhibitor (PPI) therapy and several concerns regarding chronic use of this medication class, including hypomagnesemia, fracture risk, low seurm B12 levels, anemias, and increased risk of certain infections.
28 Feb 2017
067 - Diabetes: does it cost a “heart” and a leg?
In this episode, we discuss new evidence for cardiovascular outcomes in diabetics based on the LEADER trial (liraglutide) and CANVAS trials (canagliflozin). We also discuss the new FDA warning for canagliflozin regarding amputation risk.
26 Sep 2017
048 - Self-Care of Nasal Congestion and Allergies
In this episode, we discuss the self-care of nasal congestion and allergies, including systemic/topical decongestants, nasal corticosteroids, antihistamines, cromolyn, and alternative medicine therapies.
23 Aug 2016
068 - Hooked on a feeling: how to discuss benzodiazepine tapers with your patients
In this episode, we will discuss the current state of benzodiazepine use, expected trends in prescribing, and risks associated with use. Lastly, we will discuss techniques for ensuring that a benzodiazepine taper is performed in a safe manner with lowest risk of harm.
17 Oct 2017
034 - New Injectable Insulins
In this podcast, we discuss three new injectable insulin formations: Toujeo (insulin glargine U-300), Humalog U-200 (insulin lispro), and Tresiba (insulin degludec).
3 Nov 2015
080 - HIT Me With Your Best Shot: A Brief Review of Heparin-Induced Thrombocytopenia (HIT)
In this episode, we will review the diagnosis and treatment of heparin-induced thrombocytopenia (HIT).
26 Jun 2018
032 - ARNIs and Entresto
In this episode, we discuss the new drug class, ARNI, recently approved for heart failure with a focus on sacubatril/valsartan (Entresto) and the PARADIGM-HF trial.
22 Sep 2015
086 - Everything You Need to Know About Insulins - In One Shot!
In this episode, we discuss a broad overview of insulin topics ranging from the various types of insulins, dosage forms, brand/generic names, pharmacokinetic nuances, injection technique, and a wide variety of clinical pearls.
30 Oct 2018
095 - The Ultimate Guide to NSAIDs: An In-Depth Drug Class Review
In this episode, we will review the pharmacology, efficacy, and safety of the most common NSAIDs on the market.
7 May 2019
016 - New diabetes medications
In this episode, we discuss newly approved agents for diabetes mellitus: Afrezza (inhaled human insulin), SGLT2 inhibitors (Invokana, Farxiga, Jardiance), and long-acting GLP-1 agonists (Bydureon, Tanzeum).
4 Nov 2014
094 - The Sweet Sweet Taste of Annually Updated Guidelines: 2019 Standards of Diabetes Care
In this episode, we discuss the changes made in the American Diabetes Association’s 2019 Standards of Diabetes Care guideline as well as updates in therapy recommendations per ADA and ESDA consensus statement published in Fall 2018.
16 Apr 2019
058 - Third time’s a charm -- redefining sepsis (again) using Sepsis-3
In this episode, we discuss the newest definition of sepsis and septic shock according to the Sepsis-3 criteria and the 2016 Surviving Sepsis guidelines. We also review the scoring systems of “qSOFA” and “SOFA” and use a patient case to help demonstrate the new definitions.
21 Mar 2017